LINK IMMUNOTHERAPEUTICS
Link Immunotherapeutics specializes in creating therapies through rigorous science and high-throughput observation. It focuses on known cancer targets and bispecific architectures, building on existing understanding in the pursuit of better molecules with greater patient benefit.
LINK IMMUNOTHERAPEUTICS
Industry:
Health Care Medical Therapeutics
Founded:
2019-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.linkimmunotherapeutics.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Mobile Non Scaleable Content Sitelinks Search Box Yoast WordPress SEO Plugin JsDelivr
Similar Organizations
Juno Therapeutics
Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.
Validus Cellular Therapeutics
Validus Cellular Therapeutics is a developer of therapeutic solutions for treating infectious diseases.
Current Employees Featured
Eric Gruff Chief Development Officer (CDO) @ Link Immunotherapeutics
Chief Development Officer (CDO)
2022-04-01
Official Site Inspections
http://www.linkimmunotherapeutics.com
- Host name: 24.31.154.104.bc.googleusercontent.com
- IP address: 104.154.31.24
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Link Immunotherapeutics"
Link Immunotherapeutics - LinkedIn
Link Immunotherapeutics | 408 followers on LinkedIn. Groundbreaking therapies through rigorous science. | Link selects validated cancer targets and novel target combinations to build on...See details»
Link Immunotherapeutics - Crunchbase Company …
Link Immunotherapeutics specializes in creating therapies through rigorous science and high-throughput observation. It focuses on known cancer targets …See details»
Link Immunotherapeutics - PitchBook
Developer of next-generation T-cell engaging therapies designed to treat a broad spectrum of oncology indications.See details»
Link Immunotherapeutics - VentureRadar
Website: https://www.linkimmunotherapeutics.com/ Selects validated cancer targets and novel …See details»
Link Immunotherapeutics, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Link …See details»
Overview, News & Similar companies - ZoomInfo.com
View Link Immunotherapeutics (www.linkimmunotherapeutics.com) location in Washington, …See details»
Link Immunotherapeutics - VentureRadar
"Link Immunotherapeutics' goal is to bring combination therapies into the clinic." Umoja is …See details»
Link Immunotherapeutics, Inc. · 1616 Eastlake Ave E Ste 208, …
LINK IMMUNOTHERAPEUTICS, INC. is a business entity in Seattle, Washington registered …See details»
Link Immunotherapeutics - Products, Competitors, Financials, …
Link Immunotherapeutics is a company focused on the development of groundbreaking …See details»
Next-generation combination approaches for immune checkpoint …
3 days ago · Immune checkpoint therapy has revolutionized cancer treatment, leading to …See details»
Link Immunotherapeutics, Inc. - Drug pipelines, Patents, Clinical ...
Sep 22, 2024 · Explore Link Immunotherapeutics, Inc. with its drug pipeline, therapeutic area, …See details»
Christopher Mehlin - Chief.. - Link Immunotherapeutics - ZoomInfo
Nov 23, 2022 · View Christopher Mehlin's business profile as Chief Scientific Officer at Link …See details»
Novel Macrocyclic NLRP3 Inhibitors | Journal of Medicinal Chemistry
2 days ago · Aberrant activation of NLRP3 due to persistent tissue damage, misfolded proteins …See details»
Link Immunotherapeutics Staff Directory & Email Format
Explore Link Immunotherapeutics staff directory for direct access to contact details on 17 …See details»
Ashok Bandaranayake Email & Phone number - ZoomInfo
Ashok Bandaranayake is a Vice President of Immuno-Oncology at Link Immunotherapeutics …See details»
David Meininger - GenSci - LinkedIn
With more than 26 years of industry experience, I am a seasoned biopharmaceutical… · …See details»
Link Immunotherapeutics, Inc. (Link Immunotherapeutics, Inc.) - 药 …
CT-95 is a fully humanized bispecific TCE that employs an IgG-scFv architecture with an …See details»
Scott Delbecq - Group at Link Immunotherapeutics - ZoomInfo
Get the details of Scott Delbecq's business profile including email address, phone number, …See details»
Link Immunotherapeutics, Inc. in Seattle, WA - (408) 609-0437
Link Immunotherapeutics, Inc. is in the Pharmaceutical Preparations business. View …See details»
The Republic of Poland Signs its Country Programme Framework …
8 hours ago · HE Ms Marzena Czarnecka, Minister of Industry, and Mr Hua Liu, IAEA Deputy …See details»